Dynamic Changes of Blood Lipids in Breast Cancer Patients After (Neo)adjuvant Chemotherapy: A Retrospective Observational Study

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.30620402
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Fedewa SA, Goding Sauer A, et al. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66(1):31–42. doi:10.3322/caac.2132026513636
   PubMed Web of Science ®Google Scholar
• Li T, Mello-Thoms C, Brennan PC. Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence. Breast Cancer Res Treat. 2016;159(3):395–406. doi:10.1007/s10549-016-3947-027562585
   PubMed Web of Science ®Google Scholar
• Hendrick RE, Baker JA, Helvie MA. Breast cancer deaths averted over 3 decades. Cancer. 2019;125(9):1482–1488. doi:10.1002/cncr.3195430740647
   PubMed Web of Science ®Google Scholar
• Patnaik JL, Byers T, DiGuiseppi C, et al. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011;13(3):R64. doi:10.1186/bcr290121689398
   PubMed Web of Science ®Google Scholar
• Abdel-Qadir H, et al. A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer. JAMA Cardiol. 2017;2(1):88–93.27732702
   PubMed Web of Science ®Google Scholar
• Yeo W, Mo FKF, Pang E, et al. Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy. BMC Womens Health. 2017;17(1):55. doi:10.1186/s12905-017-0409-828750616
   PubMed Web of Science ®Google Scholar
• Sharma M, Tuaine J, McLaren B, et al. Chemotherapy Agents Alter Plasma Lipids in Breast Cancer Patients and Show Differential Effects on Lipid Metabolism Genes in Liver Cells. PLoS One. 2016;11(1):e0148049. doi:10.1371/journal.pone.014804926807857
   PubMed Web of Science ®Google Scholar
• Rzymowska J. Effect of cytotoxic chemotherapy on serum lipid levels in breast cancer patients. Pathobiology. 1999;67(3):129–132. doi:10.1159/00002806210394133
   PubMed Web of Science ®Google Scholar
• Guan X, Liu Z, Zhao Z, et al. Emerging roles of low-density lipoprotein in the development and treatment of breast cancer. Lipids Health Dis. 2019;18(1):137. doi:10.1186/s12944-019-1075-731182104
   PubMed Web of Science ®Google Scholar
• Fichtali K, Bititi A, Elghanmi A, et al. Serum Lipidomic Profiling in Breast Cancer to Identify Screening, Diagnostic, and Prognostic Biomarkers. Biores Open Access. 2020;9(1):1–6. doi:10.1089/biores.2018.002232042507
   PubMed Web of Science ®Google Scholar
• Jacobson TA, Ito MK, Maki KC, et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary. J Clin Lipidol. 2014;8(5):473–488. doi:10.1016/j.jacl.2014.07.00725234560
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Merz CNB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110(2):227–239. doi:10.1161/01.CIR.0000133317.49796.0E15249516
   PubMed Web of Science ®Google Scholar
• Arpino G, De Angelis C, Buono G, et al. Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy. Breast Cancer Res Treat. 2015;154(1):127–132. doi:10.1007/s10549-015-3586-x26424165
   PubMed Web of Science ®Google Scholar
• Dieli-Conwright CM, et al. An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy. Cancer. 2016;122(17):2646–2653.27219902
   PubMed Web of Science ®Google Scholar
• Li X, Liu Z-L, Wu Y-T, et al. Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy. Lipids Health Dis. 2018;17(1):91. doi:10.1186/s12944-018-0745-129678178
   PubMed Web of Science ®Google Scholar
• Tian W, Yao Y, Fan G, et al. Changes in lipid profiles during and after (neo)adjuvant chemotherapy in women with early-stage breast cancer: A retrospective study. PLoS One. 2019;14(8):e0221866. doi:10.1371/journal.pone.022186631465521
   PubMed Web of Science ®Google Scholar
• Bjorge T, Lukanova A, Jonsson H, et al. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev. 2010;19(7):1737–1745. doi:10.1158/1055-9965.EPI-10-023020615887
   PubMed Web of Science ®Google Scholar
• Gu K, Chen X, Zheng Y, et al. Weight change patterns among breast cancer survivors: results from the Shanghai breast cancer survival study. Cancer Causes Control. 2010;21(4):621–629. doi:10.1007/s10552-009-9491-z20043201
   PubMed Web of Science ®Google Scholar
• Saquib N, et al. Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women’s healthy eating and living (WHEL) study. Breast Cancer Res Treat. 2007;105(2):177–186.17123151
   PubMed Web of Science ®Google Scholar
• Panis C, Binato R, Correa S, et al. Short infusion of paclitaxel imbalances plasmatic lipid metabolism and correlates with cardiac markers of acute damage in patients with breast cancer. Cancer Chemother Pharmacol. 2017;80(3):469–478. doi:10.1007/s00280-017-3384-828689298
   PubMed Web of Science ®Google Scholar
• Rajan VP, Menon KM. Involvement of microtubules in lipoprotein degradation and utilization for steroidogenesis in cultured rat luteal cells. Endocrinology. 1985;117(6):2408–2416. doi:10.1210/endo-117-6-24082866086
   PubMed Web of Science ®Google Scholar
• McClure MT, Stupans I. Investigation of the mechanism by which cyclophosphamide alters cytochrome P450 in male rats. Biochem Pharmacol. 1992;43(12):2655–2658. doi:10.1016/0006-2952(92)90155-C1632821
   PubMed Web of Science ®Google Scholar
• Sudharsan PT, Mythili Y, Sudhahar V, et al. Role of lupeol and its ester on cyclophosphamide-induced hyperlipidaemic cardiomyopathy in rats. J Pharm Pharmacol. 2005;57(11):1437–1444. doi:10.1211/jpp.57.11.000916259776
   PubMed Web of Science ®Google Scholar
• Manthravadi S, Shrestha A, Madhusudhana S. Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis. Int J Cancer. 2016;139(6):1281–1288. doi:10.1002/ijc.3018527176735
   PubMed Web of Science ®Google Scholar
• Kalabova H, Melichar B, Ungermann L, et al. Intima-media thickness, myocardial perfusion and laboratory risk factors of atherosclerosis in patients with breast cancer treated with anthracycline-based chemotherapy. Med Oncol. 2011;28(4):1281–1287. doi:10.1007/s12032-010-9593-120567943
   PubMed Web of Science ®Google Scholar
• Militaru A, Avram A, Cimpean AM, et al. The Assessment of Left Ventricle Function and Subclinical Atherosclerosis in Patients with Acute Myeloid Leukemia. Vivo. 2018;32(6):1599–1607. doi:10.21873/invivo.11420
   Web of Science ®Google Scholar
• Kim Y, Park SK, Han W, et al. Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea. Cancer Epidemiol Biomarkers Prev. 2009;18(2):508–515. doi:10.1158/1055-9965.EPI-08-013319190159
   PubMed Web of Science ®Google Scholar
• Sahebkar A, Serban M-C, Penson P, et al. The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: systematic Review and Meta-Analysis. Drugs. 2017;77(11):1187–1197. doi:10.1007/s40265-017-0767-428573436
   PubMed Web of Science ®Google Scholar
• Chi F. Effects of toremifene versus tamoxifen on breast cancer patients: a meta-analysis. Breast Cancer. 2013;20(2):111–122.23266963
   PubMed Web of Science ®Google Scholar
• Amir E, Seruga B, Niraula S, et al. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst. 2011;103(17):1299–1309. doi:10.1093/jnci/djr24221743022
   PubMed Web of Science ®Google Scholar